The Italian Network for Tumor Biotherapy (NIBIT): Getting together to push the field forward

Michele Maio, Hugues J M Nicolay, Paolo Ascierto, Filippo Belardelli, Roberto Camerini, Mario P. Colombo, Paola Queirolo, Ruggero Ridolfi, Vincenzo Russo, Lucia Anzalone, Ester Fonsatti, Giorgio Parmiani

Research output: Contribution to journalArticlepeer-review


As for a consolidated tradition, the 5th annual meeting of the Italian Network for Cancer Biotherapy took place in the Certosa of Pontignano, a Tuscan monastery, on September 20-22, 2007. The congress gathered more than 40 Italian leading groups representing academia, biotechnology and pharmaceutical industry. Aim of the meeting was to share new advances in cancer bio-immunotherapy and to promote their swift translation from pre-clinical research to clinical applications. Several topics were covered including: a) molecular and cellular mechanisms of tumor escape; b) therapeutic antibodies and recombinant constructs; c) clinical trials up-date and new programs; d) National Cooperative Networks and their potential interactions; e) old and new times in cancer immunology, an "amarcord". Here, we report the main issues discussed during the meeting.

Original languageEnglish
Article number8
JournalJournal of Translational Medicine
Publication statusPublished - Feb 12 2008

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)


Dive into the research topics of 'The Italian Network for Tumor Biotherapy (NIBIT): Getting together to push the field forward'. Together they form a unique fingerprint.

Cite this